Ensatinib hydrochloride capsules are used in locally advanced patients with kinase-positive mesenchymal lymphoma that has progressed after treatment with crizotinib or is intolerant to crizotinib and in patients with metastatic non-small cell lung cancer.
Adverse reactions include rash, pruritus, abnormal liver function, nausea, constipation, vomiting, abdominal discomfort, diarrhea, malaise, fever, abdominal pain, dysgeusia, headache, dizziness, etc. Use is contraindicated in patients who are hypersensitive to the active ingredient of the product or any of the excipients.
Should be under the guidance of a doctor to buy, use this drug, to prevent the occurrence of adverse reactions, during the use of drugs, pay attention to do not drink alcohol, light diet, pay attention to rest, follow the doctor’s instructions to take the drug on time, and pay attention to the review, the emergence of discomfort in a timely manner, to prevent the occurrence of adverse consequences.